Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/the-toxicology-handbook/descriptif_4720971
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=4720971

The Toxicology Handbook (4th Ed.)

Langue : Anglais

Auteurs :

Couverture de l’ouvrage The Toxicology Handbook

Now in its fourth edition, the Toxicology Handbook is Australia's leading reference guide for quick and evidence-informed decision making on treatment of the acutely poisoned patient.

The book has been streamlined and fully updated to provide a comprehensive yet concise guide for all medical practitioners and health-care professionals who deal with poisonings. It contains quickly accessible information on poisons, toxins, antidotes, envenomings and antivenoms, and uses a structured and rigorous risk assessment-based approach to guide appropriate treatment decisions.

Written by leading Australian specialists in toxicology and informed by the latest clinical research, this is a must-have addition to all emergency departments and poison information centres.

  • Concisely written - helps the student, trainee, and clinician to find information quickly and easily
  • A simple, easily remembered and elegant framework (R RSI DEAD) forming the basis of care for all toxicology patients
  • Fully revised content, streamlined to be more user-friendly
  • Evidence based and up to date - supports appropriate decision making
  • Helps resolve common treatment dilemmas, including for digoxin and lithium poisoning, corrosive ingestions and management of envenomings
  • Written and edited by experts in the field of toxicology
  • An eBook included in all print purchases
  • Expanded information on agents that are seen with increasing frequency in poisoned patients, including lamotrigine and pregabalin
  • Updated detail on the management of agents including direct oral anticoagulants, digoxin, desvenlafaxine and corrosives
  • Updated and standardised treatment recommendations for dysrhythmias, particularly resulting from drug-induced conduction abnormalities (QRS and QT prolongation)
  • Simplified and standardised approaches to management (particularly cardiovascular toxicity from a variety of agents)

CHAPTER 1 APPROACH TO THE POISONED PATIENT 1.1 Overview 1.2 Resuscitation 1.3 Risk assessment 1.4 Supportive care and monitoring 1.5 Investigations 1.6 Gastrointestinal decontamination 1.7 Enhanced elimination 1.8 Antidotes 1.9 Description

CHAPTER 2 SPECIFIC CONSIDERATIONS 2.1 Coma 2.2 Hypotension 2.3 Seizures 2.4 Approach to delirium 2.5 Serotonin toxicity 2.6 Anticholinergic toxicity 2.7 Cholinergic toxicity 2.8 Neuroleptic malignant syndrome 2.9 Alcohol use disorder 2.10 Amphetamine use disorder  2.11 Opioid use disorder 2.12 Sedative-hypnotic use disorder 2.13 Solvent abuse 2.14 Body packers and stuffers 2.15 Osmolar gap 2.16 Acid-base disorders  2.17 The 12-lead ECG in toxicology 2.18 Approach to mushroom poisoning 2.19 Approach to plant poisoning 2.20 Poisoning during pregnancy and lactation 2.21 Poisoning in children 2.22 Poisoning in the elderly

CHAPTER 3 SPECIFIC TOXINS 3.1 Alcohol: Ethanol 3.2 Alcohol: Ethylene glycol 3.3 Alcohol: Isopropanol (isopropyl alcohol) 3.4 Alcohol: Methanol (methyl alcohol) 3.5 Alcohol: Other toxic alcohols 3.6 Amisulpride 3.7 Amphetamines and amphetamine-like substances 3.8 Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) 3.9 Anticoagulant rodenticides 3.10 Anticonvulsants: Newer agents 3.11 Antihistamines (non-sedating) 3.12 Antihistamines (sedating) 3.13 Arsenic 3.14 Baclofen 3.15 Barbiturates 3.16 Benzodiazepines 3.17 Benztropine 3.18 Beta-blockers 3.19 Bupropion 3.20 Button batteries 3.21 Calcium channel blockers (CCBs) 3.22 Cannabinoids and synthetic cannabinoid receptor agonists (SCRAs) 3.23 Carbamazepine 3.24 Carbon monoxide 3.25 Chloroquine and hydroxychloroquine 3.26 Chloral hydrate 3.27 Clonidine and other central ?2-adrenergic agonists 3.28 Clozapine 3.29 Cocaine 3.30 Colchicine 3.31 Corrosives 3.32 Cyanide 3.33 Digoxin: Acute overdose 3.34 Digoxin: Chronic poisoning 3.35 Diphenoxylate-atropine 3.36 Direct oral anticoagulants 3.37 Gamma-hydroxybutyrate (GHB) 3.38 Glyphosate 3.39 Hydrocarbons 3.40 Hydrofluoric acid 3.41 Hydrogen peroxide 3.42 Insulin 3.43 Iron 3.44 Isoniazid 3.45 Lamotrigine 3.46 Lead 3.47 Lithium: Acute overdose 3.48 Lithium: Chronic poisoning 3.49 Local anaesthetic agents 3.50 Mercury 3.51 Metformin 3.52 Methotrexate 3.53 Mirtazapine 3.54 Monoamine oxidase inhibitors (MAOIs) 3.55 Non-steroidal anti-inflammatory drugs (NSAIDs) 3.56 Olanzapine 3.57 Opioids 3.58 Organochlorines 3.59 Organophosphorus agents (organophosphates and carbamates) 3.60 Paracetamol: Immediate-release preparations (acute overdose) 3.61 Paracetamol: Modified-release formulations 3.62 Paracetamol: Repeated supratherapeutic ingestion 3.63 Paraquat 3.64 Phenothiazines and butyrophenones (antipsychotic agents) 3.65 Phenytoin 3.66 Potassium chloride 3.67 Pregabalin 3.68 Quetiapine  3.69 Quinine 3.70 Risperidone 3.71 Salicylates 3.72 Selective serotonin reuptake inhibitors (SSRIs) 3.73 Strychnine 3.74 Sulfonylureas 3.75 Theophylline 3.76 Thyroxine 3.77 Tramadol and tapentadol 3.78 Tricyclic antidepressants (TCAs) 3.79 Valproic acid (sodium valproate)  3.80 Venlafaxine and desvenlafaxine 3.81 Warfarin

CHAPTER 4 ANTIDOTES 4.1 Atropine 4.2 Calcium 4.3 Cyproheptadine 4.4 Desferrioxamine 4.5 Digoxin immune fab 4.6 Dimercaprol 4.7 DMSA (succimer) and DMPS (unithiol) 4.8 Ethanol 4.9 Flumazenil 4.10 Folinic acid 4.11 Fomepizole 4.12 Glucose 4.13 Hydroxocobalamin 4.14 Insulin (high-dose) 4.15 Intravenous lipid emulsion 4.16 Methylene blue 4.17 N-acetylcysteine 4.18 Naloxone  4.19 Octreotide 4.20 Penicillamine 4.21 Physostigmine 4.22 Pralidoxime 4.23 Pyridoxine 4.24 Sodium bicarbonate 4.25 Sodium calcium edetate 4.26 Sodium thiosulfate 4.27 Vitamin K

CHAPTER 5 ENVENOMINGS 5.1 Approach to snakebite 5.2 Black snake 5.3 Brown snake 5.4 Death adder 5.5 Tiger snake group 5.6 Taipan 5.7 Sea snakes 5.8 Australian scorpions 5.9 Bluebottle jellyfish (Physalia species) 5.10 Stonefish 5.11 Box jellyfish 5.12 Irukandji syndrome 5.13 Blue-ringed octopus 5.14 Redback spider 5.15 Funnel-web (big black) spider 5.16 White-tailed spider 5.17 Ticks

CHAPTER 6 ANTIVENOMS 6.1 Black Snake Antivenom 6.2 Brown Snake Antivenom 6.3 Death Adder Antivenom 6.4 Tiger Snake Antivenom 6.5 Taipan Antivenom 6.6 Sea Snake Antivenom 6.7 Polyvalent Snake Antivenom 6.8 Stonefish Antivenom 6.9 Box Jellyfish Antivenom 6.10 Redback Spider Antivenom 6.11 Funnel-Web Spider Antivenom 6.12    Allergic Reactions to Antivenom

Date de parution :

Ouvrage de 560 p.

Réapprovisionnement en cours

78,42 €

Ajouter au panier

Ces ouvrages sont susceptibles de vous intéresser